I'll grant you that -- 45,000 people a year. How many will actually take the next step to get a $1,000 (wholesale) treatment that costs presumably a ton more retail?
How many will even go to the doctor in the first place? How many will just write it off as pink eye that will go away and/or have no clue there is a cure in the first place if the miracle happens that NNVC actually gets a drug on the market?
I think my 25% figure is extremely and ridiculously optimistic and generous.
Parading around figures that assume 100% of people take a $1,000 (wholesale price) drug and all of that money goes directly to NNVC as pure bottom line profit without any expenses whatsoever, including the $7 million in overhead, and ballooning, that is already there -- is so reckless even Seymour wouldn't do that.
Market Data 
Markets 
AI
